Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate MofetilReportar como inadecuado




Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Case Reports in Hematology - Volume 2016 2016, Article ID 9495761, 4 pages -

Case ReportWarwick Hospital, Lakin Road, Warwick, Warwickshire CV34 5BW, UK

Received 13 March 2016; Revised 11 June 2016; Accepted 3 July 2016

Academic Editor: Yoshihiro Matsukawa

Copyright © 2016 Sarah Green et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Autoimmune haemolytic anaemia is not a well-recognised complication of sarcoidosis. We describe the case of a 30-year-old female who presented with acute warm haemolytic anaemia and widespread lymphadenopathy. Sarcoidosis was diagnosed on lymph node biopsy and further investigation. The haemolytic anaemia responded only to a high dose of steroids. Evidence regarding treatment of steroid refractory autoimmune haemolysis secondary to sarcoidosis is lacking. Based on the emergent evidence that both disorders share common immunopathogenic mechanisms involving Th1 and Th17 lymphocytes, our patient was given rituximab and mycophenolate mofetil to successfully suppress the haemolysis and sarcoid activity.





Autor: Sarah Green, Erica Partridge, Edore Idedevbo, and Anton Borg

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados